Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment

Ali Amidi*, Mads Agerbæk, Lisa M. Wu, Anders D. Pedersen, Mimi Mehlsen, Cecilie R. Clausen, Ditte Demontis, Anders D. Børglum, Anja Harbøll, Robert Zachariae

*Kontaktforfatter

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstract

Evidence suggests that testicular cancer (TC) and its treatment are associated with cognitive impairment. However, the underlying neural substrate and biological mechanisms are poorly understood. This study aimed to investigate changes in cognition and brain grey matter (GM) morphology in TC patients undergoing treatment, and to explore associations with immune markers, endocrine markers, and genotype. Sixty-five patients with stage I-III TC underwent assessment after surgery but prior to further treatment and again 6 months after. Twenty-two patients received chemotherapy (+CT), while 43 did not (−CT). Assessments included neuropsychological testing, whole-brain magnetic resonance imaging, and blood samples. Twenty-five healthy controls (HCs) underwent neuropsychological testing with a matching time interval. A regression-based approach was used to determine cognitive changes and longitudinal voxel-based morphometry (VBM) was performed to investigate changes in GM density in the TC groups. Compared with the HCs, both TC groups showed higher rates of cognitive decline (p 
OriginalsprogEngelsk
TidsskriftBrain Imaging and Behavior
Vol/bind11
Udgave nummer3
Sider (fra-til)769-783
ISSN1931-7557
DOI
StatusUdgivet - 1. jun. 2017

Fingeraftryk

Dyk ned i forskningsemnerne om 'Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment'. Sammen danner de et unikt fingeraftryk.

Citationsformater